195 related articles for article (PubMed ID: 16449997)
1. Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice.
Huynh CK; Brodie AM; Njar VC
Br J Cancer; 2006 Feb; 94(4):513-23. PubMed ID: 16449997
[TBL] [Abstract][Full Text] [Related]
2. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC
Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344
[TBL] [Abstract][Full Text] [Related]
3. Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice.
Patel JB; Huynh CK; Handratta VD; Gediya LK; Brodie AM; Goloubeva OG; Clement OO; Nanne IP; Soprano DR; Njar VC
J Med Chem; 2004 Dec; 47(27):6716-29. PubMed ID: 15615521
[TBL] [Abstract][Full Text] [Related]
4. Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents.
Patel JB; Khandelwal A; Chopra P; Handratta VD; Njar VC
Cancer Chemother Pharmacol; 2007 Nov; 60(6):899-905. PubMed ID: 17345084
[TBL] [Abstract][Full Text] [Related]
5. Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts.
Gediya LK; Belosay A; Khandelwal A; Purushottamachar P; Njar VC
Bioorg Med Chem; 2008 Mar; 16(6):3352-60. PubMed ID: 18166465
[TBL] [Abstract][Full Text] [Related]
6. MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours.
Khandelwal A; Gediya L; Njar V
Br J Cancer; 2008 Apr; 98(7):1234-43. PubMed ID: 18349838
[TBL] [Abstract][Full Text] [Related]
7. Effects of new 17alpha-hydroxylase/C(17,20)-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo.
Grigoryev DN; Long BJ; Nnane IP; Njar VC; Liu Y; Brodie AM
Br J Cancer; 1999 Oct; 81(4):622-30. PubMed ID: 10574247
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
Njar VC; Gediya L; Purushottamachar P; Chopra P; Vasaitis TS; Khandelwal A; Mehta J; Huynh C; Belosay A; Patel J
Bioorg Med Chem; 2006 Jul; 14(13):4323-40. PubMed ID: 16530416
[TBL] [Abstract][Full Text] [Related]
9. First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds.
Purushottamachar P; Patel JB; Gediya LK; Clement OO; Njar VC
Eur J Med Chem; 2012 Jan; 47(1):412-23. PubMed ID: 22130607
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo.
Koshiuka K; Elstner E; Williamson E; Said JW; Tada Y; Koeffler HP
Br J Cancer; 2000 Jan; 82(2):452-8. PubMed ID: 10646904
[TBL] [Abstract][Full Text] [Related]
11. Murine toxicology and pharmacokinetics evaluation of retinoic acid metabolism blocking agent (RAMBA), VN/12-1.
Godbole AM; Purushottamachar P; Martin MS; Njar VC
Cancer Chemother Pharmacol; 2012 Aug; 70(2):339-44. PubMed ID: 22580781
[TBL] [Abstract][Full Text] [Related]
12. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy.
Njar VC
Mini Rev Med Chem; 2002 Jun; 2(3):261-9. PubMed ID: 12370067
[TBL] [Abstract][Full Text] [Related]
14. Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity.
McCaffery P; Simons C
Curr Pharm Des; 2007; 13(29):3020-37. PubMed ID: 17979744
[TBL] [Abstract][Full Text] [Related]
15. Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells.
Bilip M; Shah S; Mathiyalakan M; Tagalakis AD; Hart SL; Maeshima R; Eaton S; Orford M; Irving E; Di Florio A; Simons C; Stoker AW
J Drug Target; 2020 Jul; 28(6):643-654. PubMed ID: 31903789
[TBL] [Abstract][Full Text] [Related]
16. Autophagy inhibition synergistically enhances anticancer efficacy of RAMBA, VN/12-1 in SKBR-3 cells, and tumor xenografts.
Godbole AM; Purushottamachar P; Martin MS; Daskalakis C; Njar VC
Mol Cancer Ther; 2012 Apr; 11(4):898-908. PubMed ID: 22334589
[TBL] [Abstract][Full Text] [Related]
17. Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.
Eskra JN; Kuiper JW; Walden PD; Bosland MC; Özten N
Eur J Cancer Prev; 2017 Jan; 26(1):71-77. PubMed ID: 26886237
[TBL] [Abstract][Full Text] [Related]
18. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
Sun B; Song S; Hao CZ; Huang WX; Liu CC; Xie HL; Lin B; Cheng MS; Zhao DM
J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
[TBL] [Abstract][Full Text] [Related]
19. Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells.
Nehmé A; Varadarajan P; Sellakumar G; Gerhold M; Niedner H; Zhang Q; Lin X; Christen RD
Br J Cancer; 2001 Jun; 84(11):1571-6. PubMed ID: 11384110
[TBL] [Abstract][Full Text] [Related]
20. Effect of conjugates of all-trans-retinoic acid and shorter polyene chain analogues with amino acids on prostate cancer cell growth.
Sadikoglou E; Magoulas G; Theodoropoulou C; Athanassopoulos CM; Giannopoulou E; Theodorakopoulou O; Drainas D; Papaioannou D; Papadimitriou E
Eur J Med Chem; 2009 Aug; 44(8):3175-87. PubMed ID: 19375825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
